前列腺癌放疗后病灶PSMA PET信号动力学:单中心回顾性研究
病灶摄取在放疗后9-12个月最低;PET2残留摄取更常见于放疗后较早时间点成像、前列腺/前列腺床病灶及基线SUVmax较高者。预测L-CR的最佳时间点为8.6个月。
要点
- 放疗后PSMA PET病灶摄取随时间降低,9-12个月最低。
- 残留摄取更常见于放疗后较早成像、前列腺/前列腺床病灶及高基线SUVmax者。
- 预测L-CR的最佳评估时间点为8.6个月。
核心结论
- 放疗后PSMA PET信号受成像时间点和肿瘤部位影响,评估放疗后反应时应考虑这两个因素。
主要发现
- 病灶摄取在较晚时间点更低,放疗后9-12个月最低。
- 68个病灶在PET2显示残留摄取。
- 残留摄取更常见于放疗后较早时间点成像的病灶(中位7.9 vs 13.0个月,p=0.001)、前列腺/前列腺床病灶(p<0.001)及基线SUVmax较高的病灶(p=0.001)。
- 未达到L-CR的危险因素为摄取持续时间延长(p=0.002)和前列腺/前列腺床病灶(p=0.003)。
关键数值与推荐
- 预测L-CR的最佳时间点为8.6个月(受试者工作特征曲线分析)。
- 随访扫描形态学或摄取消失定义为局部区域完全缓解(L-CR)。
临床怎么用
- 评估放疗后PSMA PET反应时,应考虑成像时间点和肿瘤部位。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the kinetics of prostate-specific membrane antigen (PSMA) PET uptake in irradiated lesions using serial PSMA PET/CT scans. METHODS: Patients with prostate cancer who underwent 68Ga-PSMA-11 PET/CT before (PET1) and after radiotherapy (PET2) were retrospectively included. Percentage changes in SUVmax (ΔSUVmax) of the irradiated lesion were measured. The presence of residual uptake was visually assessed on PET2. When available, follow-up imaging was used for lesion validation. Morphologic or uptake disappearance on follow-up scans was defined as loco-regional complete response (L-CR). Clinical and PET characteristics were compared between lesions with and without residual uptake. An optimal timing for response assessment was calculated by receiver-operating-curve analysis. RESULTS: Eighty-nine patients with 217 irradiated lesions (106 lymph nodes, 85 bone, 21 prostate/prostate bed) receiving ablative radiotherapy were included. Lesion uptake was lower at later time points and was lowest at 9-12 months after radiotherapy. Sixty-eight lesions showed residual uptake on PET2. Residual uptake was more common in lesions imaged at an earlier time point after radiotherapy (median: 7.9 vs. 13.0 months, p = 0.001), lesions in the prostate/prostate bed (p < 0.001), and lesions with higher baseline SUVmax (p = 0.001). Thirty-one residual uptake-positive lesions had available follow-up imaging, of which 24 lesions were confirmed to be L-CR. Risk factors for not achieving L-CR were lesions with prolonged uptake (p = 0.002) and those in the prostate/prostate bed (p = 0.003). The optimal time point for predicting L-CR was 8.6 months. CONCLUSIONS: Timing and tumor site affect the PSMA PET signal after radiotherapy, and should be considered when assessing response on post-radiotherapy PSMA PET.
引用
- Hotta M, Nguyen K, Thin P, et al. Kinetics of PSMA PET signal after radiotherapy in prostate cancer lesions: A single-center retrospective study. Radiother Oncol. 2025. PMID: 40122284. doi:10.1016/j.radonc.2025.110869
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。